China In-Vitro Diagnostics Research Report 202: A $28.13 Billion Market by 2030, Driven by High Burden of Chronic and Infectious Diseases

Key Facts

• Due to the upsurge in the geriatric population and the high burden of chronic and infectious diseases, like diabetes, cancer, and COVID-19, the China IVD market is slated to show significant growth, as these chronic disorders can be diagnosed and monitored using in-vitro diagnostics products.
• By Segment: China In-Vitro Diagnostics Market and Forecast - Key Takeaways * Immunoassay and Clinical Chemistry are the leading segments of the China IVD market.
• China In-Vitro Diagnostics Market - Company Analysis * In the China IVD market, Roche Diagnostics is the leader with a majority share, followed by Mindray Medical International Limited and Shanghai Kehua Bio-Engineering Co. Ltd.
• • Kindstar Global BGI-Shenzhen OriGene Technologies This 282 Page report with 43 Figures and 5 Tables has been analyzed from 12 View Points: China IVD Market and Forecast (2014 - 2030) China IVD Market Share and Forecast (2014 - 2030) By Segment - China IVD Market & Forecast (2014 - 2030) Development Environment and Regulatory Status in China IVD market China IVD Market - Key Players Sales Analysis (2015 - 2030) Registration for In-Vitro Diagnostic Reagents in China Regulatory History/Status/Trends in China IVD Market Reimbursement of IVD Products in China Profiles of Select Private Clinical Labs and Diagnostic Services Companies IVD Market - Major Deals IVD Market - Recent Developments China IVD Industry - Market Dynamics China IVD Market - By Application Segment Clinical Chemistry Immunoassays Hematology Coagulation Microbiology Molecular Testing Self-Monitoring of Blood Glucose (SMBG) Point of Care Testing (POCT) For more information about this report visit https://www.researchandmarkets.com/r/kz3uhv About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data.

Click To Read Full Article